Committee Composition

  Audit Nominating and Governance Compensation & Mgmt Development Mergers and Acquisitions
Rolf A. Classon Chairman of the Board Independent Director   Committee Chair for Nominating and Governance Committee   Committee Chair for Mergers and Acquisitions Committee
John J. Greisch        
John Greisch President and CEO, Hill-Rom Holdings, Inc.

Mr. Greisch, was elected President & Chief Executive Officer of Hill-Rom effective January 8, 2010. Mr. Greisch was most recently President International Operations for Baxter International, Inc., a position he held since 2006. During his seven year tenure with Baxter, he also served as Baxter's Chief Financial Officer and as President of Baxter's BioScience division. Before his time with Baxter, he was President & CEO for FleetPride Corporation in Deerfield, Ill., an independent after-market distribution company serving the transportation industry. Prior to his tenure at FleetPride, he held various positions at The Interlake Corporation in Lisle, Ill., a leading global engineered materials and industrial equipment supplier, including serving as President of the company's Materials Handling Group. Mr. Greisch currently serves on the Board of Directors of Idorsia Pharmaceuticals Ltd and AdvaMed, and previously served on the Board of Directors of Actelion Ltd. Additionally, he is on the Board of Directors for Ann & Robert H. Lurie Children's Hospital of Chicago. Through January 2010, Mr. Greisch served as a director of TomoTherapy, Inc.

As the CEO of Hill-Rom, Mr. Greisch brings valuable multinational experience with multiple roles in a major public healthcare company, including as Chief Financial Officer, as well as operational insights and business knowledge to the Board.


William G. Dempsey Independent Director Member of Audit Committee      
Gary L. Ellis Independent Director Member of Audit Committee      
Stacy Enxing Seng Independent Director     Member of Compensation & Mgmt Development Committee  
Mary Garrett Independent Director Member of Audit Committee      
James R. Giertz Independent Director Member of Audit Committee      
Charles E. Golden Independent Director Committee Chair for Audit Committee Member of Nominating and Governance Committee   Member of Mergers and Acquisitions Committee
William H. (Hank) Kucheman Independent Director     Member of Compensation & Mgmt Development Committee Member of Mergers and Acquisitions Committee
Ronald A. Malone Independent Director   Member of Nominating and Governance Committee Committee Chair for Compensation & Mgmt Development Committee Member of Mergers and Acquisitions Committee
Nancy M. Schlichting Independent Director     Member of Compensation & Mgmt Development Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member Independent Director = Independent Director


Meetings and Committees of the Board of Directors

It is the general policy of the Company that all significant decisions be considered by the Board as a whole. As a consequence, the committee structure of the Board is limited to those committees considered to be basic to, or required for, the operation of a publicly owned company. Currently these committees are the Compensation and Management Development Committee, Audit Committee and Nominating/Corporate Governance Committee, each of which has a written charter adopted by the Board of Directors. The Nominating/Corporate Governance Committee recommends the members and chairs of these committees to the Board. The Audit Committee, Compensation and Management Development Committee and Nominating/Corporate Governance Committee are made up of only independent directors. The current charter for each of the Board's standing committees is available on this website and is available in print from this website or to any shareholder who requests it through the Company's Investor Relations office.

During the fiscal year ended September 30, 2009, the Board of Directors of the Company held seven meetings. During this period, no member of the Board of Directors attended fewer than 75% of the aggregate of the number of meetings of the full Board of Directors and the number of meetings of the committees on which he or she served.




PDF Download PDF   55.0 KB   Add to Briefcase

PDF Download PDF  225.9 KB   Add to Briefcase

PDF Download PDF  142.3 KB   Add to Briefcase